drugset / Trial / NCT03733171

Platelet Rich Plasma in Bleeding Peptic Ulcer

NCT03733171

Unknown 80 enrolled Zagazig University
RandomizedParallel-groupOpen-labelTreatment

Summary

The most common cause of acute upper gastrointestinal bleeding (UGIB) is non-variceal, where peptic ulcer bleeding (PUB) remains the single most common cause, accounting for 25% to 67% of the causes of non-variceal upper gastrointestinal bleeding (NVUGIB). Despite major advances in diagnostic and therapeutic tools, PUB remains a significant problem and an important cause of morbidity and mortality. Given the imperative therapeutic role of endoscopic management in achieving hemostasis in NVUGIB, new modalities to improve the current treatment strategies continue to be developed. Platelet-rich plasma (PRP) is a widely used throughout many fields of medicine for improving tissue regeneration. PRP contains a higher concentration of platelets than whole blood, and represents a pool of many growth-factors.

Timeline

Start
2018-09-20
Primary completion
2019-06-01
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified 1 ml Other
Comparator Epinephrine Other / unclassified 2 ml Other
Comparator Platelet Rich Plasma Other / unclassified 1 ml Other
Comparator Platelet Rich Plasma Other / unclassified 2 ml Other